These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

738 related items for PubMed ID: 23403206

  • 1. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Pignot G, Colin P, Zerbib M, Audenet F, Soulié M, Hurel S, Delage F, Irani J, Descazeaud A, Droupy S, Rozet F, Phé V, Ruffion A, Long JA, Crouzet S, Houlgatte A, Bigot P, Guy L, Faïs PO, Rouprêt M, French Collaborative National Database on UUT-UC.
    Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C.
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [Abstract] [Full Text] [Related]

  • 3. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS.
    Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
    [Abstract] [Full Text] [Related]

  • 4. Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
    Liu Y, Lu J, Hong K, Huang Y, Ma L.
    Urol Oncol; 2014 Feb; 32(2):146-52. PubMed ID: 23628312
    [Abstract] [Full Text] [Related]

  • 5. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, De La Taille A, Arroua F, Marchand C, Matte A, Fais PO, Rouprêt M, French Collaborative National Database on U.U.T.-U.C.
    BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration.
    Fradet V, Mauermann J, Kassouf W, Rendon R, Jacobsen N, Fairey A, Izawa J, Kapoor A, Black P, Tanguay S, Chin J, So A, Lattouf JB, Bell D, Saad F, Sheyegan B, Drachenberg D, Cagiannos I, Lacombe L.
    Urol Oncol; 2014 Aug; 32(6):839-45. PubMed ID: 24856978
    [Abstract] [Full Text] [Related]

  • 7. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
    Wheat JC, Weizer AZ, Wolf JS, Lotan Y, Remzi M, Margulis V, Wood CG, Montorsi F, Roscigno M, Kikuchi E, Zigeuner R, Langner C, Bolenz C, Koppie TM, Raman JD, Fernández M, Karakiewizc P, Capitanio U, Bensalah K, Patard JJ, Shariat SF.
    Urol Oncol; 2012 Aug; 30(3):252-8. PubMed ID: 20451416
    [Abstract] [Full Text] [Related]

  • 8. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W.
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [Abstract] [Full Text] [Related]

  • 9. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V.
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [Abstract] [Full Text] [Related]

  • 10. Upper Tract Urothelial Carcinomas Accompanied by Previous or Synchronous Nonmuscle-Invasive Bladder Cancer and Preoperative Hydronephrosis Might Have Worse Oncologic Outcomes After Radical Nephroureterectomy.
    Liang C, Chi R, Huang L, Wang J, Liu H, Xu D, Qian S, Qian X, Qi J.
    Clin Genitourin Cancer; 2016 Oct; 14(5):e469-e477. PubMed ID: 27021588
    [Abstract] [Full Text] [Related]

  • 11. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Rink M, Sharifi N, Fritsche HM, Aziz A, Miller F, Kluth LA, Ngamsri T, Dahlem R, Chun FK, Shariat SF, Stenzl A, Fisch M, Gakis G.
    J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
    [Abstract] [Full Text] [Related]

  • 12. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J, Kikuchi E, Tanaka N, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakagawa K, Oya M.
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [Abstract] [Full Text] [Related]

  • 13. Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.
    Kuroda K, Asakuma J, Horiguchi A, Tasaki S, Yoshii H, Sato A, Ito K, Seguchi K, Sumitomo M, Asano T.
    Urol Int; 2012 Nov; 88(2):225-31. PubMed ID: 22236640
    [Abstract] [Full Text] [Related]

  • 14. Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter.
    Dalpiaz O, Ehrlich G, Quehenberger F, Pummer K, Zigeuner R.
    Urol Oncol; 2014 Jan; 32(1):34.e1-8. PubMed ID: 23506964
    [Abstract] [Full Text] [Related]

  • 15. Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.
    Youssef RF, Shariat SF, Lotan Y, Cost N, Wood CG, Sagalowsky AI, Zigeuner R, Langner C, Chromecki TF, Montorsi F, Bolenz C, Margulis V.
    Urol Oncol; 2013 Jul; 31(5):676-81. PubMed ID: 21704538
    [Abstract] [Full Text] [Related]

  • 16. Predictive factors for bladder recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Cho DS, Kim SI, Ahn HS, Kim SJ.
    Urol Int; 2013 Jul; 91(2):153-9. PubMed ID: 23391941
    [Abstract] [Full Text] [Related]

  • 17. The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study.
    Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Shirotake S, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, Hayakawa N, Kosaka T, Oyama M, Miyajima A, Momma T, Nakagawa K, Jinzaki M, Nakajima Y, Oya M.
    Urol Oncol; 2014 Jan; 32(1):48.e19-26. PubMed ID: 24055429
    [Abstract] [Full Text] [Related]

  • 18. Effects of Previous or Synchronous Non-Muscle Invasive Bladder Cancer on Clinical Results after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multi-Institutional Study.
    Kim BW, Ha YS, Lee JN, Kim HT, Kim TH, Lee JK, Byun SS, Choi YD, Kang HW, Yun SJ, Kim WJ, Kwon YS, Kwon TG.
    Urol J; 2015 Sep 04; 12(4):2233-9. PubMed ID: 26341764
    [Abstract] [Full Text] [Related]

  • 19. The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma.
    Gurbuz C, Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Margulis V.
    J Endourol; 2011 May 04; 25(5):775-9. PubMed ID: 21388245
    [Abstract] [Full Text] [Related]

  • 20. Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature.
    Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Khalil D, Kapur P, Shariat SF, Raj GV, Sagalowsky AI, Cadeddu JA, Lotan Y, Margulis V.
    Urol Oncol; 2014 Jan 04; 32(1):54.e19-26. PubMed ID: 24360665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.